Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection

por Nathwani, Dilip, Cornely, Oliver A., Van Engen, Anke K., Odufowora-Sita, Olatunji, Retsa, Peny, Odeyemi, Isaac A. O.
Publicado 2014

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

por Aballéa, Samuel, Maman, Khaled, Thokagevistk, Katia, Nazir, Jameel, Odeyemi, Isaac A. O., Hakimi, Zalmai, Garnham, Andy, Toumi, Mondher
Publicado 2014